Compounds > 14,15-epoxy-5,8,11-eicosatrienoic acid
Page last updated: 2024-10-21

14,15-epoxy-5,8,11-eicosatrienoic acid and Atherogenesis

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Atherogenesis in 1 studies

14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imaizumi, S1
Grijalva, V1
Navab, M1
Van Lenten, BJ1
Wagner, AC1
Anantharamiah, GM1
Fogelman, AM1
Reddy, ST1

Other Studies

1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Atherogenesis

ArticleYear
L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.
    Drug metabolism letters, 2010, Volume: 4, Issue:3

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Anti-Inflammatory Agents; Apolipoproteins E; Atherosclerosis;

2010